Ingestion of thioproline suppresses rat esophageal adenocarcinogenesis caused by duodenogastroesophageal reflux

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1443-1449

  Sasaki, Shozo ^a   Miwa, Koichi ^b   Fujimura, Takashi ^a   Oba, Masaru ^a   Miyashita, Tomoharu ^a   Kinami, Shinichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Toyama Rosai Hospital   (Japan)

Author keywords

Columnar lined epithelium; Duodenogastroesophageal reflux; Esophageal adenocarcinogenesis; N nitroso compound; Thioproline

Indexed keywords

THIAZOLIDINE DERIVATIVE; THIAZOLIDINE-4-CARBOXYLIC ACID; TIMONACIC; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL; ARTICLE; DISEASE MODEL; DUODENUM; ESOPHAGUS TUMOR; FISCHER 344 RAT; GASTROESOPHAGEAL REFLUX; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; RAT;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; DUODENUM; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; MALE; RATS; RATS, INBRED F344; THIAZOLIDINES;

EID: 38449086407     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1443     Document Type: Article

References (47)

1. Devesa SS, Blot WJ and Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053, 1998. (Pubitemid 28525384)
2. Pera M, Cameron AJ, Trastek VF, Carpenter HA and Zinsmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104: 510-513, 1993. (Pubitemid 23033424)
3. Hongo M and Shoji T: Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 38 (Suppl 15): 25-30, 2003. (Pubitemid 36442881)
4. Cameron AJ, Otto BJ and Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. New Engl J Med 313: 857-859, 1985. (Pubitemid 15250200)
5. Attwood SEA, DeMeester TR, Bremnar CG, Barlow AP and Hinder RA: Alkaline gastroesophageal reflux: implication in the development of complication in Barrett's columnar lower esophagus. Surgery 106: 764-770, 1989. (Pubitemid 19255088)
6. Championg G, Richter JE, Vaezi MF, Singh S and Alexander R: Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 107: 747-754, 1994. (Pubitemid 24265522)
7. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremnar CG and Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 222: 525-531, 1995.
8. Melo LL, Kruel CDP, Kliemann LM, et al: Influence of surgical induced gastric and gastroduodenal content reflux on esophageal carcinogenesis - experimental model in Wistar female rats. Dis Esophagus 12: 106-115, 1999.
9. Miwa K, Sahara H, Segawa M, et al: Reflux of duodenal or gastro-duodenal contents induce esophageal carcinoma in rats. Int J Cancer 67: 269-274, 1996. (Pubitemid 26274160)
10. Miwa K, Segawa M, Takano Y, et al: Induction of esophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 70: 185-189, 1994. (Pubitemid 24247134)
11. Goldstein SR, Yang G, Curtis SK, et al: Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18: 2265-2270, 1997. (Pubitemid 28134757)
12. Fein M, Peters JH, Chandrasoma P, et al: Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2: 260-268, 1998. (Pubitemid 128409612)
13. Pera M, Brito M, Pera M, et al: Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis 21: 1587-1591, 2000. (Pubitemid 30601650)
14. Mirvish SS, Huang Q, Chen SC, et al: Metabolism of carcinogenic nitrosoamines in the rat and human esophagus and indication of esophageal adenocarcinoma in rats. Endoscopy 25: 627-631, 1993. (Pubitemid 24002743)
15. Watt PC, Sloan JM, Donaldoson JD, Patterson CC and Kennedy TL: Relationship between histology and gastric juice pH and nitrite in the stomach after operation for duodenal ulcer. Gut 25: 246-252, 1984. (Pubitemid 14127883)
16. Correa P, Haenszel W, Cuello C, Tannenbaum S and Archer M: A model for gastric cancer epidemiology. Lancet 12: 58-60, 1975.
17. Mirvish SS: Formation of N-nitroso compounds: chemistry, kinetics and in vivo occurrence. Toxicol Appl Pharmacol 31: 325-351, 1975.
18. Calmels S, Bereziat JC, Ohshima H and Bartsch H: Bacterial formation of N-nitroso compounds from administered precursors in the rat stomach after omeprazole induced achlorhydria. Carcinogenesis 12: 435-439, 1991.
19. Suzuki K and Mitsuoka T: N-nitrosoamine formation by intestinal bacteria. IARC Sci Publ 57: 275-281, 1984.
20. Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93: 17-48, 1995.
21. Lee JS, Oh TY, Ahn BO, et al: Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 480-481: 189-200, 2001. (Pubitemid 32744827)
22. Wetscher GJ, Hinder RA, Bagchi D, et al: Reflux esophagitis in humans is mediated by oxygen-derived free radical. Am J Surg 170: 552-557, 1995.
23. Wetscher GJ, Perdikis G, Ketchmar DH, et al: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 40: 1297-1305, 1995.
24. Wilson KT, Fu S, Ramanujam KS and Meltzer SJ: Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58: 2929-2934, 1998. (Pubitemid 28335064)
25. Goldstein SR, Yang GY, Chen X, Curtis SK and Yang CS: Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19: 1445-1449, 1998. (Pubitemid 28409843)
26. Ratner S and Clarke HT: The action of Formaldehyde upon cysteine. J Am Chem Soc 59: 200-206, 1937.
27. Tahira T, Tsuda M, Wakabayashi K, Nagao M and Sugimura T: Kinetics of nitrosation of thioproline, the precursor of a major nitroso compound in human urine, and its role as a nitrite scavenger. GANN 75: 889-894, 1984. (Pubitemid 15216265)
28. Weber HU, Fleming JF and Miquel J: Thiazolidine-4-carboxylic acid, a physiologic sulfhydryl antioxidant with potential value in geriatric medicine. Arch Gerontol Geriatr 1: 299-310, 1982. (Pubitemid 13124573)
29. Tahira T, Ohgaki H, Wakabayashi K, Nagao M and Sugimura T: The inhibitory effect of thioproline on carcinogenesis induced by N-benzylmethylamine and nitrite. Fd Chem Toxic 26: 511-516, 1988.
30. Nakai M: Inhibitory effect of Thioproline on gastric carcinogenesis in rats with surgically induced duodenogastric reflux. Journal of the Juzen Medical Society 105: 648-657, 1996 (In Japanese).
31. Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G and Hattori T: Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 25: 723-727, 2004. (Pubitemid 38618523)
32. Sato T, Miwa K, Sahara H, Segawa M and Hattori T: The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res 26: 565-570, 2005.
33. Mirvish SS: The etiology of gastric cancer. J Natl Cancer Inst 71: 629-647, 1983.
34. Busby WF, Shuker DEG, Charnley G, Newberne PM, Tannenbaum SR and Wogen GN: Carcinogenicity in rats of the nitrosated bile acid and conjugates N-nitrosoglycocholic acid and N-nitrosotaurocholic acid. Cancer Res 45: 1367-1371, 1985. (Pubitemid 15111305)
35. Nishijima K, Miwa K, Miyashita T, et al: Impact of biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240: 57-67, 2004. (Pubitemid 38808235)
36. Oyama K, Fujimura T, Ninomiya I, et al: A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. Carcinogenesis 26: 565-570, 2005. (Pubitemid 41214145)
37. Garnier R, Efthymiou ML and Fournier E: Acute thioproline poisoning. J Toxicol Clin Toxcol 19: 289-295, 1982. (Pubitemid 12005386)
38. Brugarolas A and Gosalvez M: Treatment of cancer by an inducer of reverse transformation. Lancet 1: 68-70, 1980. (Pubitemid 10199403)
39. Nasca S, Galichet V, Jardillier JC, Garbe E and Coninx P: Thioproline toxicity. Lancet 1: 778, 1981. (Pubitemid 11153921)
40. Eiserich JP, Hristova M, Cross CE, et al: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998. (Pubitemid 28093514)
41. Crow JP and Ischiropoulos S: Detection and quantization of nitrotyrosine residue in proteins: in vivo marker of peroxynitrite. Methods Enzymol 269: 185-194, 1996. (Pubitemid 26295707)
42. Miwa K, Fujimura T, Hasegawa H, et al: Is bile or are pancreaticoduodenal secretions related to gastric carcinogenesis in rats with reflux through the pylorus? J Cancer Res Clin Oncol 118: 570-574, 1992.
43. Mason RC: Duodenogastric reflux in rat gastric carcinoma. Br J Surg 73: 801-803, 1986.
44. Yamashita Y, Homma K, Kako N, et al: Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats. J Gastrointest Surg 2: 350-355, 1998. (Pubitemid 128423121)
45. Pera M, Trastek VF, Carpenter HA, et al: Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 55: 1386-1393, 1993. (Pubitemid 23189384)
46. Pera M, Grande L, Gelabert M, et al: Epithelial cell hyperproliferation after biliopancreatic reflux into the esophagus of rats. Ann Thorac Surg 65: 779-786, 1998. (Pubitemid 28184179)
47. Fein M, Fuchs KH, Stopper H, Diem S and Herderich M: Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 21: 2079-2084, 2000.